Position in DSGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,178,422
+$417,149 QoQ
Shares Held
204,739
+9.0% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. DSGN ranks #53 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in DSGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,178,422 | 204,739 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,761,273 | 187,769 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $100,188 | 16,238 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $77,353 | 14,378 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $41,593 | 12,416 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $44,652 | 11,080 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $94,393 | 35,620 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $84,063 | 35,620 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $122,409 | 19,430 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||